Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Cathie Wood’s ARK ETF bolsters CRISPR stock, trims Moderna By Investing.com
    News

    Cathie Wood’s ARK ETF bolsters CRISPR stock, trims Moderna By Investing.com

    userBy userOctober 17, 2024No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    Cathie Wood’s ARK ETF published their daily trades for Thursday, October 17th, 2024, with a notable focus on the biotech sector. The most significant investment of the day was in CRISPR Therapeutics AG (NASDAQ:CRSP), where ARK bought a total of 91,665 shares across its ARKK and ARKG ETFs, amounting to a substantial $4,491,585. This purchase continues a trend for ARK, which has been consistently increasing its stake in the gene-editing company, indicating a strong conviction in CRISPR’s potential.

    Another major buy for the day was in Cerus Corp (NASDAQ:), with ARK acquiring 466,684 shares for a total value of $840,031. This move suggests a growing interest in the biomedical products company, as it was the second-largest dollar-value trade of the day.

    ARK also increased its holdings in Intellia Therapeutics Inc (NASDAQ:) by purchasing 29,739 shares valued at $612,028, further emphasizing its bet on the genomics industry. Additionally, ARK bought shares in Blade Air Mobility Inc (NASDAQ:) and 3D Systems Corp (NYSE:NYSE:), with total dollar values of $19,488 and $35,611, respectively.

    On the sell side, ARK reduced its exposure to Moderna Inc (NASDAQ:) by selling 19,544 shares for a total of $1,122,998. This follows a pattern of selling in the biotechnology company observed over the past week. ARK also continued to divest from Markforged Holding Corp (NYSE:MKFG) and Materialise NV (NASDAQ:), with sales amounting to $2,047 and $40,870, respectively.

    Investors following ARK’s trades might note the continued interest in the genomic sector, with consistent buys in companies like CRISPR Therapeutics and Intellia Therapeutics. The sales in Moderna and ongoing reductions in positions like Markforged Holding suggest a strategic shift in ARK’s portfolio composition.

    Overall, today’s trades indicate a clear focus on innovative healthcare technologies, aligning with Cathie Wood’s vision of investing in disruptive innovation. As ARK continues to adjust its holdings, market watchers and investors alike will be keen to see how these bets play out in the dynamic landscape of technological advancements.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleINL invites executives from Google, Amazon and more to learn about investing in the future of nuclear energy
    Next Article Climate Change Calculus: HNWIs and Sustainable Impact Investing
    user
    • Website

    Related Posts

    £10,000 invested in Standard Chartered shares 2 years ago is now worth…

    June 8, 2025

    Over the next 10 years, I think I’ll make the most money in this area of the stock market

    June 8, 2025

    Here’s how investors can target a £50k passive income in retirement with an ISA!

    June 8, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d